Acadia Healthcare Co. (ACHC) Rating Reiterated by JPMorgan Chase & Co.
Acadia Healthcare Co. (NASDAQ:ACHC)‘s stock had its “hold” rating reissued by stock analysts at JPMorgan Chase & Co. in a report issued on Tuesday. They currently have a $61.00 price target on the stock. JPMorgan Chase & Co.’s target price would indicate a potential upside of 27.78% from the stock’s previous close.
ACHC has been the subject of several other research reports. Robert W. Baird restated an “outperform” rating and set a $69.00 price target on shares of Acadia Healthcare in a report on Tuesday, June 14th. Zacks Investment Research lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, July 11th. RBC Capital Markets reiterated an “outperform” rating and issued a $78.00 price objective (down previously from $86.00) on shares of Acadia Healthcare in a research note on Monday, August 1st. Leerink Swann reiterated an “outperform” rating and issued a $80.00 price objective on shares of Acadia Healthcare in a research note on Monday. Finally, Royal Bank Of Canada lowered their price objective on shares of Acadia Healthcare from $86.00 to $78.00 and set an “outperform” rating for the company in a research note on Monday, August 1st. One research analyst has rated the stock with a sell rating, one has given a hold rating and twelve have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $77.21.
Acadia Healthcare (NASDAQ:ACHC) opened at 47.74 on Tuesday. Acadia Healthcare has a 1-year low of $47.07 and a 1-year high of $74.77. The firm has a market cap of $4.17 billion, a price-to-earnings ratio of 25.50 and a beta of 0.84. The company has a 50-day moving average of $51.13 and a 200-day moving average of $55.22.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Friday, July 29th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.73. Acadia Healthcare had a net margin of 6.44% and a return on equity of 9.35%. The firm earned $756.50 million during the quarter, compared to analyst estimates of $752.57 million. During the same quarter last year, the business earned $0.57 EPS. The company’s revenue was up 66.8% compared to the same quarter last year. Analysts predict that Acadia Healthcare will post $2.64 earnings per share for the current year.
In related news, major shareholder Waud Capital Partners Iii, L.L sold 457,443 shares of the business’s stock in a transaction dated Friday, September 16th. The shares were sold at an average price of $48.39, for a total value of $22,135,666.77. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, major shareholder Waud Capital Partners Ii, L.L. sold 54,254 shares of the business’s stock in a transaction dated Tuesday, September 13th. The stock was sold at an average price of $51.71, for a total transaction of $2,805,474.34. The disclosure for this sale can be found here. Company insiders own 17.20% of the company’s stock.
Several institutional investors have recently modified their holdings of the company. Loomis Sayles & Co. L P increased its position in shares of Acadia Healthcare by 15.1% in the first quarter. Loomis Sayles & Co. L P now owns 372,070 shares of the company’s stock worth $20,505,000 after buying an additional 48,864 shares during the period. AXA increased its position in shares of Acadia Healthcare by 11.8% in the first quarter. AXA now owns 94,500 shares of the company’s stock worth $5,208,000 after buying an additional 10,000 shares during the period. Park Avenue Institutional Advisers LLC bought a new position in shares of Acadia Healthcare during the first quarter worth $471,000. State Street Corp increased its position in shares of Acadia Healthcare by 30.4% in the first quarter. State Street Corp now owns 890,807 shares of the company’s stock worth $49,096,000 after buying an additional 207,605 shares during the period. Finally, TimesSquare Capital Management LLC increased its position in shares of Acadia Healthcare by 11.0% in the first quarter. TimesSquare Capital Management LLC now owns 1,234,005 shares of the company’s stock worth $68,006,000 after buying an additional 121,940 shares during the period.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.
Receive News & Stock Ratings for Acadia Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Co. and related stocks with our FREE daily email newsletter.